General MedicationsORALGeneric
SEROPHENE
CLOMIPHENE CITRATE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview SEROPHENE is listed in Drugs@FDA under application 018361 (NDA).
Marketing status: Discontinued Active ingredient CLOMIPHENE CITRATE Form and strength TABLET;ORAL - 50MG Sponsor EMD SERONO Submission history Latest submission status date: 2003-07-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview SEROPHENE is listed in Drugs@FDA under application 018361 (NDA). Marketing status: Discontinued Active ingredient CLOMIPHENE CITRATE Form and strength TABLET;ORAL - 50MG Sponsor EMD SERONO Submission history Latest submission status date: 2003-07-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.